Beauty Health Q3 EPS $(0.56) Misses $0.09 Estimate, Sales $97.40M Miss $116.30M Estimate
Portfolio Pulse from Benzinga Newsdesk
Beauty Health (NASDAQ:SKIN) reported a significant Q3 EPS loss of $(0.56), which was a miss against the $0.09 estimate, marking a 722.22% miss and a 1220% decrease from the $0.05 per share earned in the same period last year. Sales were $97.40M, also missing the $116.30M estimate by 16.25%, despite being a 9.69% increase from the previous year's sales of $88.79M.
November 13, 2023 | 9:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Beauty Health's Q3 earnings and sales significantly missed analyst estimates, indicating potential negative investor sentiment and a possible short-term decline in stock price.
The substantial miss in both earnings per share and sales compared to analyst estimates typically leads to negative investor sentiment and a decrease in stock price in the short term. The magnitude of the miss, especially in earnings per share (EPS), which is a key indicator of a company's profitability, is likely to be viewed unfavorably by the market. The year-over-year decrease in EPS further compounds the negative outlook, as it suggests a significant deterioration in the company's profitability.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100